Skip to main content

Investor Relations

Platform

Our platform is revolutionizing the way medicines and materials are designed by enabling highly accurate molecular predictions in silico.

Pipeline

We are rapidly advancing a deep pipeline of potential first-in-class or best-in-class collaborative and proprietary molecules against validated targets in multiple therapeutic areas.

Materials Science

Our computational platform enables scientists across a wide range of industries to discover, optimize, and formulate the materials of the future.

Latest News

View All News

Latest events & presentation

View All Events

SCHRÖDINGER CORPORATE PRESENTATION

More results quarterly results

Quick Links

IR Contact

IR@schrodinger.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Schrödinger, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section. If you experience any issues with this process, please contact us for further assistance.

By providing your email address, you are providing consent to Schrödinger, Inc. to send you the requested Investor Email Alert updates.

* Required

Investor Alert Options
Unsubscribe
© Schrödinger, Inc. - All rights reserved
Powered By Q4 Inc. 5.143.9.1 (opens in new window)
opens in new window